The A-TANGO consortium performs Phase II clinical studies of an innovative therapeutic strategy, called "G-TAK", to fight end-stage cirrhosis and ACLF.

ID:1361316953944698880

linkhttps://atango.eu/ calendar_today15-02-2021 14:12:56